Market Overview

Seres Therapeutics (NASDAQ: MCRB)

3.51 -0.05 (-1.40%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2020
Pre-Market
EPS:
REV:
-0.23
7.031M



Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
-0.59
7.321M



Q4 2019
Pre-Market
EPS:
REV:
-0.52
10.629M



Q3 2019
Pre-Market
EPS:
REV:
-0.54
9.055M

-0.23
7.031M

Q2 2019
Pre-Market
EPS:
REV:
-0.68
4.612M
-0.48
8.13M
-0.24
12.531M
50%
54.13%
Q1 2019
Pre-Market
EPS:
REV:
-0.69
3.971M
-0.38
17.07M
-0.59
7.321M
-55.26%
-57.11%
Q4 2018
Pre-Market
EPS:
REV:
-0.72
3.056M
-0.50
13.1M
-0.52
10.629M
4%
-18.86%
Q3 2018
Pre-Market
EPS:
REV:
-0.17
23.015M
-0.52
11.37M
-0.54
9.055M
3.85%
-20.36%
Q2 2018
Pre-Market
EPS:
REV:
-0.69
3.014M
-0.63
6.57M
-0.68
4.612M
7.94%
-29.8%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!